Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
HIV Medicine
|
September 20, 2014
Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients
F A Gonzalez, E Van den Eynde, S Perez-Hoyos, et al.
Journal of Neurovirology
|
November 28, 2008
Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up
S Villar del Saz, O Sued, V Falcó, et al.
Inorganic Chemistry
|
June 26, 2001
Hybrid molecular materials based upon organic pi-electron donors and metal complexes. Radical salts of bis(ethylenethia)tetrathiafulvalene (BET-TTF) with the octahedral anions hexacyanoferrate(III) and nitroprusside. The first kappa phase in the BET-TTF family
M Clemente-León, E Coronado, J R Galán-Mascarós, et al.
HIV Medicine
|
June 26, 2012
Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital
M Riveiro-Barciela, V Falcó, J Burgos, et al.
Archives of Internal Medicine
|
October 20, 1998
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users
E Ribera, J M Miró, E Cortés, et al.
The Journal of Antimicrobial Chemotherapy
|
August 9, 2007
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
I Molina, V Falcó, M Crespo, et al.
HIV Medicine
|
January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study
E Ribera, M Larrousse, A Curran, et al.
HIV Medicine
|
December 16, 2014
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio
E Martínez, E Ribera, B Clotet, et al.
HIV Medicine
|
June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease
A Imaz, V Falcó, M Peñaranda, et al.
Journal of Viral Hepatitis
|
March 27, 2007
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
M Crespo, S Sauleda, J I Esteban, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
HIV Medicine
|
September 20, 2014
Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients
F A Gonzalez, E Van den Eynde, S Perez-Hoyos, et al.
Journal of Neurovirology
|
November 28, 2008
Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up
S Villar del Saz, O Sued, V Falcó, et al.
Inorganic Chemistry
|
June 26, 2001
Hybrid molecular materials based upon organic pi-electron donors and metal complexes. Radical salts of bis(ethylenethia)tetrathiafulvalene (BET-TTF) with the octahedral anions hexacyanoferrate(III) and nitroprusside. The first kappa phase in the BET-TTF family
M Clemente-León, E Coronado, J R Galán-Mascarós, et al.
HIV Medicine
|
June 26, 2012
Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital
M Riveiro-Barciela, V Falcó, J Burgos, et al.
Archives of Internal Medicine
|
October 20, 1998
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users
E Ribera, J M Miró, E Cortés, et al.
The Journal of Antimicrobial Chemotherapy
|
August 9, 2007
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
I Molina, V Falcó, M Crespo, et al.
HIV Medicine
|
January 10, 2013
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study
E Ribera, M Larrousse, A Curran, et al.
HIV Medicine
|
December 16, 2014
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio
E Martínez, E Ribera, B Clotet, et al.
HIV Medicine
|
June 4, 2009
Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease
A Imaz, V Falcó, M Peñaranda, et al.
Journal of Viral Hepatitis
|
March 27, 2007
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
M Crespo, S Sauleda, J I Esteban, et al.
Page
of 14